Treatment of hepatocellular carcinoma at the dawn of the third millennium: Liver transplantation and its alternatives

Acta Gastro-Enterologica Belgica

Volumn 67, Issue 2, 2004, Pages 206-222

  Majno, Pietro ^a   Mentha, G ^b   Giostra, E ^b   Terraz, S ^b   Rubbia Brandt, L ^b   Berney, Th ^b   Buhler, L ^b   Toso, Ch ^b   Huber, O ^b   Spahr, L ^b   Morard, I ^b   Hadengue, A ^b   Becker, Ch ^b   Terrier, F ^b   Morel, Ph ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

CANCER CHEMOTHERAPY; CANCER SCREENING; CANCER STAGING; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ECHOGRAPHY; HEMOCHROMATOSIS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MASS SCREENING; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 3042796949     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. PARKIN D.M., BRAY F., FERLAY J., PISANI P. Estimating the world cancer burden. GLOBOCAN 2000. Int. J. Cancer, 2001, 94: 153-156.
2. BRUIX J., SHERMAN M., LLOVET J.M., BEAUGRAND M., LENCIONI R., BURROUGHS A.K., CHRISTENSEN E., PAGLIARO L., COLOMBO M., RODES J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J. Hepatol., 2001, 35: 421-30.
3. FATTOVICH G., GIUSTINA G., SCHALM S.W. et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B: the EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology, 1995, 21: 77-82.
4. GANNE-CARIE N., CHASTANG C., CHAPEL F. et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology, 1996, 23: 1112-1118.
5. COLOMBO M., DE FRANCHIS R., DEL NINNO E., SANGIOVANNI A., DE FAZIO C., TOMMASINI M. et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N. Engl. J. Med., 1991, 325: 675-680.
6. BRUNO S., SILINI E., CROSIGNANI A., BORZIO F., LEANDRO G., BONO F. et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study. Hepatology, 1997, 25: 754-758.
7. TSUKUMA H., HIYAMA T., TANAKA S., NAKAO M., YABUUCHI T., KITAMURA T., NAKANISHI K., FUJIMOTO I., INOUE A., YAMAZAKI H. et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med., 1993, 328: 1797-801.
8. DEGOS F., CHRISTIDIS C., GANNE-CARRIE N., FARMACHIDI J.P., DEGOTT C., GUETTIER C. et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut, 2000, 47: 131-136.
9. OKA H., TAMORI A., KUROKI T., KOBAYASHI K., YAMAMOTO S. Prospective study of alpha-foetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology, 1994, 19: 61-66.
10. BORZIO M., BRUNO S., RONCALLI M., MELS G.C., RAMELLA G., BORZIO F. et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology, 1995, 108: 812-817.
11. BOLONDI L. Screening for hepatocellular carcinoma in cirrhosis. J. Hepatol., 2003, 39: 1076-84.
12. BOLONDI L., SOFIA S., SIRINGO S., GAIANI S., CASALI A., ZIRONI G., PISCAGLIA F. et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut, 2001, 48: 251-259.
13. ARII S., YAMAOKA Y., FUTAGAWA S., INOUE K., KOBAYASHI K., KOJIRO M., MAKUUCHI M. et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular caricnomas: a retrospective and nationwide survey in Japan. Hepatology, 2000, 32: 1224-1229.
14. SATO S., SHIRATORI Y., IMAMURA M., TERATANI T., OBI S., KOIKE Y., IMAI Y., YOSHIDA H., SHIINA S., OMATA M. Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J. Hepatol., 2001, 35: 225-234.
15. LLOVET J.M., BURROUGHS A., BRUIX J. Hepatocellular carcinoma. Lancet, 2003, 362: 1907-17.
16. LENCIONI R., CIONI D., BARTOLOZZI C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur. Radiol., 2002, 12: 151-65.
17. LO C. et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology, 2002, 35: 1164-1171.
18. LLOVET J. et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular caricnoma A randomised controlled trial. Lancet, 2002, 359: 1734-1739.
19. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology, 1995, 17: 27-35.
20. BORZIO M., FARGION S., BORZIO F., FRACANZANI A.L., CROCE A.M., STROFFOLINI T., OLDANI S., COTICHINI R., RONCALLI M. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J. Hepatol., 2003, 39: 208-14.
21. DURAND F., REGIMBEAUD J.M., BELGHITI J. et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J. Hepatol., 2001, 35: 254-258.
22. LLOVET J.M., BRU C., BRUIX J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis., 1999, 19: 329-38.
23. BISMUTH H., CHICHE L., ADAM R., CASTAING D., DIAMOND T., DENNISON A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann. Surg., 1993, 218: 145-51.
24. MAZZAFERRO V., REGALIA E., DOCI R., ANDREOLA S., PULVIRENTI A., BOZZETI F., MONTALTO F. et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med., 1996, 334: 693-699.
25. OKEN M.M., CREECH R.H., TORMEY D.C., HORTON J., DAVIS T.E., MC FADDEN E.T., CARBONE P.P. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 1982, 5: 649-655.
26. LLOVET J.M., BUSTAMANTE J., CASTELLS A., VILANA R., AYUSO MDEL C., SALA M., BRU C., RODES J., BRUIX J. Natural history of untreated hepatocellular carcinoma: rationale for design and evaluation of therapeutic trials. Hepatology, 1999, 29: 62-67.
27. OKUDA K., OHTSUKI T., OBATA H., TOMIMATSU M., OKAZAKI N., HASEGAWA H., NAKAJIMA Y., OHNISHI K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer, 1985, 56: 918-28.
28. LIVER CANCER STUDY GROUP OF JAPAN. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer, 1994, 74: 2272-2280.
29. CLIP. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology, 2000, 31: 840-845.
30. CHEVRET S., TRINCHET J.C., MATHIEU D., RACHED A.A., BEAUGRAND M., CHASTANG C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J. Hepatol., 1999, 31: 133-141.
31. LEUNG T.W., TANG A.M., ZEE B. et al. Construction of the Chinese University prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the liver Italian program staging system: a study based on 926 patients. Cancer, 2002, 94: 1760-1769.
32. BISMUTH H., MAJNO P., ADAM R. Hepatocellular carcinoma: from ethanol injection to liver transplantation. Acta Gastroenterol. Belg., 1999, 62: 330-41.
33. LENCIONI R., PINTO F., ARMILLOTTA N., BASSI A.M., MORETTI M., DI GIULIO M., MARCHI S., ULIANA M., DELLA CAPANNA S., LENCIONI M., BARTOLOZZI C. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur. Radiol., 1997, 7: 514-9.
34. SHIINA S., TAGAWA K., NIWA Y., UNUMA T., KOMATSU Y., YOSHIURA K., HAMADA E., TAKAHASHI M., SHIRATORI Y., TERANO A. et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am. J. Roentgenol., 1993, 160: 1023-8.
35. CASTELLS A., BRUIX J., BRU C. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology, 1993, 18: 1121-1126.
36. LENCIONI R.A., ALLGAIER H.P., CIONI D., OLSCHEWSKI M., DEIBERT P., CROCETTI L., FRINGS H., LAUBENBERGER J., ZUBER I., BLUM H.E., BARTOLOZZI C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology, 2003, 228: 235-40.
37. LLOVET J.M., VILANA R., BRU C., BIANCHI L., SALMERON J.M., BOIX L., GANAU S., SALA M., PAGES M., AYUSO C., SOLE M., RODES J., BRUIX J. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology, 2001, 33: 1124-9.
38. MULIER S., MULIER P., NI Y., MIAO Y., DUPAS B., MARCHAL G., DE WEVER I., MICHEL L. Complications of radiofrequency coagulation of liver tumours. Br. J. Surg., 2002, 89: 1206-22.
39. BUSCARINI E., BUSCARINI L. Eur. Radiol. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol., 2004, 14: 31-7.
40. DE BAERE T., RISSE O., KUOCH V., DROMAIN C., SENGEL C., SMAYRA T., GAMAL EL DIN M., LETOUBLON C., ELIAS D. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am. J. Roentgenol., 2003, 181: 695-700.
41. KELEKIS A.D., TERRAZ S., ROGGAN A., TERRIER F., MAJNO P., MENTHA G., ROTH A., BECKER C.D. Percutaneous treatment of liver tumors with an adapted probe for cooled-tip, impedance-controlled radiofrequency ablation under open-magnet MR guidance: initial results. Eur Radiol., 2003, 13: 1100-5.
42. KITAMOTO M., IMAGAWA M., YAMADA H., WATANABE C., SUMIOKA M., SATOH O., SHIMAMOTO M., KODAMA M., KIMURA S., KISHIMOTO K., OKAMOTO Y., FUKUDA Y., DOHI K. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am. J. Roentgenol., 2003, 181: 997-1003.
43. BISMUTH H., MAJNO P.E. Hepatobiliary surgery. J. Hepatol., 2000, 32: 208-24.
44. IMAMURA H., SEYAMA Y., KOKIJDO N., MAEMA A., SUGAWARA Y., SANO K., TAKAYAMA T., MAKUUCHI M. One thousand fifty-six hepatectomies without mortality in 8 years. Arch. Surg., 2003. 138: 1198-1206.
45. FAN S.T., LO C.M., LIU C.L., LAM C.M., YUEN W.K., YEUNG C., WONG J. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann. Surg., 1999, 229: 322-30.
46. CHA C.H., RUO L., FONG Y., JARNAGIN W.R., SHIA J., BLUMGART L.H., DEMATTEO R.P. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann. Surg., 2003, 238: 315-323.
47. LLOVET J.M., FUSTER J., BRUIX J. lntention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology, 1999, 39: 1434-1440.
48. TAKAYAMA T., MAKUUCHI M. Ablation of hepatocellular carcinoma. Jpn. J. Clin. Oncol., 2001, 31: 297-8.
49. SUGAWARA Y., YAMAMOTO J., HIGASHI H., YAMASAKI S., SHIMADA K., KOSUGE T., TAKAYAMA T., MAKUUCHI M. Preoperative portal embolization in patients with hepatocellular carcinoma. World J. Surg., 2002, 26: 105-10.
50. AZOULAY D., CASTAING D., KRISSAT J., SMAIL A., HARGREAVES G.M., LEMOINE A., EMILE J.F., BISMUTH H. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann. Surg. 2000, 232: 665-72.
51. KO S., NAKAJIMA Y., KANEHIRO H., HISANAGA M., AOMATSU Y., KIN T., YAGURA K., OHYAMA T., NISHIO K., OHASHI K., SHO M., YAMADA T., NAKANO H Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Ann. Surg., 1996, 224: 591-5.
52. SHIRABE K., TAKENAKA K., TAKETOMI A., KAWAHARA N., YAMAMOTO K., SHIMADA M., SUGIMACHI K. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer, 1996, 77: 1050-5.
53. REGIMBEAU J.M., ABDALLA E.K., VAUTHEY J.N., LAUWERS G.Y., DURAND F., NAGORNEY D.M., IKAI I., YAMAOKA Y., BELGHITI J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J. Surg. Oncol., 2004, 85: 36-41.
54. MINAGAWA M., MAKUUCHI M., TAKAYAMA T., KOKUDO N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann. Surg., 2003, 238: 703-10.
55. MUTO Y., MORIWAKI H., NINOMIYA M. et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N. Engl. J. Med., 1996, 334: 1561-1567.
56. TAKAYAMA T., MAKUUCHI S., HIROHASHI S. et al. Early hepatocellular carcinoma as an entity with high rate of surgical cure. Hepatology, 1998, 28: 1241-1246.
57. LAU W.Y., LEUNG T.W., HO S.K., CHAN M., MACHIN D., LAU J., CHAN A.T., YEO W., MOK T.S., YU S.C., LEUNG N.W., JOHNSON P.J. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet, 1999 6, 353 (9155): 797-801.
58. BOUCHER E., CORBINAIS S., ROLLAND Y., BOURGUET P., GUYADER D., BOUDJEMA K., MEUNIER B., RAOUL J.L. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology, 2003, 38: 1237-41.
59. KUBO S., NISHIGUCHI S., HIROHASHI K., TANAKA H., SHUTO T., KINOSHITA H. Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br. J. Surg., 2002, 89: 418-22.
60. SCHWARTZ J.D., SCHWARTZ M., MANDELI J., SUNG M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol., 2002, 3: 593-603.
61. ARII S., YAMAOKA Y., FUTAGAWA S., INOUE K., KOBAYASHI K., KOJIRO M., MAKUUCHI M. et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology, 2000, 32: 1224-1229.
62. MAZZAFERRO V., REGALIA E., COPPA J., PULVIRENTI A., ROMITO R., SCHAIVO M. Viability of HCC cells after radiofrequency thermal. - MAZZAFERRO V., BATTISTON C., PERRONE S., PULVIRENTI A., REGALIA E., ROMITO R., SARLI D., SCHIAVO M., GARBAGNATI F., MARCHIANO A., SPREAFICO C., CAMERINI T., MARIANI L., MICELI R., ANDREOLA S. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann. Surg., 2004 in press.
63. MAJNO P.E., ADAM R., BISMUTH H., CASTAING D., ARICHE A., KRISSAT J., PERRIN H., AZOULAY D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann. Surg., 1997. 226: 688-703.
64. BISMUTH H., MAJNO P., ADAM R. Liver transplantation for hepatocellular carcinoma. Seminars in liver disease. 1999, 19: 311-322.
65. FIGUERAS J., IBANEZ L., RAMOS E., JAURRIETA E., ORTIZ-DEURBINA J., PARDO F., MIR J., LOINAZ C., HERRERA L., LOPEZ-CILLERO P., SANTOYO J. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl., 2001, 7: 877-83.
66. HERRERO J.I., SANGRO B., QUIROGA J., PARDO F., HERRAIZ M., CIENFUEGOS JA., PRIETO J. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl., 2001, 7: 631-6.
67. TAMURA S., KATO T., BERHO M., MISIAKOS E.P., O'BRIEN C., REDDY K.R., NERY J.R., BURKE G.W., SCHIFF E.R., MILLER J., TZAKIS A.G. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch. Surg., 2001, 136: 25-31.
68. JONAS S., BECHSTEIN W.O., STEINMLILLER T., HERRMANN M., RADKE C., BERG T., SETTMACHER U., NEUHAUS P. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology, 2001, 33: 1080-6.
69. GONDOLESI G., MUNOZ L., MATSUMOTO C., FISHBEIN T., SHEINER P., EMRE S. et al. Hepatocellular carcinoma: A prime indication for living donor liver transplantation. J. Gastrointest. Surg., 2002, 6: 102-107.
70. MOYA A., BERENGUER M., AGUILERA V., JUAN F.S., NICOLAS D., PASTOR M., LOPEZ-ANDUJAR R., RAYON M., ORBIS F., MORA J., DE JUAN M., CARRASCO D., VILA J.J., PRIETO M., BERENGUER J., MIR J. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C? Liver Transpl., 2002, 8: 1020-7.
71. YAO F. et al. Liver transplantation for hepatocellular carcinoma: Expansion of tumor size limits does not adversely impact survival. Hepatology, 2001, 33: 1394-1403.
72. KAIHARA S., KIUCHI T., UEDA M., OIKE F., FUJIMOTO Y., OGAWA K. et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation, 2003, 75 (suppl): S37-S40.
73. ADAM R., AZOULAY D., CASTAING D., ESHKENAZY R., PASCAL G., HASHIZUME K., SAMUEL D., BISMUTH H. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann. Surg., 2003, 238: 508-19.
74. BELGHITI J., CORTES A., ABDALLA E.K., REGIMBEAU J.M., PRAKASH K., DURAND F., SOMMACALE D., DONDERO F., LESURTEL M., SAUVANET A., FARGES O., KIANMANESH R. Resection prior to liver transplantation for hepatocellular carcinoma. Ann. Surg., 2003, 238: 885-93.
75. LLOVET J.M., MAS X., APONTE J.J., FUSTER J., NAVASA M., CHRISTENSEN E., RODES J., BRUIX J. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut, 2002, 50: 123-8
76. ROAYAIE S., FRISCHER J.S., EMRE S.H., FISHBEIN T.M., SHEINER P.A., SUNG M., MILLER C.M., SCHWARTZ M.E. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann. Surg., 2002, 235: 533-9.
77. GRAZIADEI I.W., SANDMUELLER H., WALDENBERGER P., KOENIGSRAINER A., NACHBAUR K., JASCHKE W., MARGREITER R., VOGEL W. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl., 2003, 9: 557-63.
78. GECH. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N. Engl. J. Med., 332: 1256-61.
79. Swiss association for the study of the liver website. http://www.SASL.ch.
80. IWATSUKI S., DVORCHIK I., MARSH J.W., MADARIAGA J.R., CARR B., FUNG J.J., STARZL T.E. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J. Am. Coll. Surg., 2000, 191: 389-94.
81. STEINMULLER T., PASCHER A., SAUER I., THERUVATH T., MULLER A., SETTMACHER U., NEUHAUS P. Living-donation liver transplantation for hepalocellular carcinoma: time to drop the limitations? Transplant. Proc., 2002, 34: 2263-4.
82. YAO F.Y., FERRELL L., BASS N.M., BACCHETTI P., ASCHER N.L., ROBERTS J.P. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl., 2002, 8: 765-74.
83. BRUIX J., LLOVET J.M. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl., 2003, 9: 700-2.
84. AZOULAY D., JOHANN M., RACCUIA J.S., CASTAING D., BISMUTH H. "Protected" double needle biopsy technique for hepatic tumors. J. Am. Coll. Surg., 1996, 183: 160-3.
85. TERRAZ S., RUBBIA-BRANDT L., MAJNO P., MENTHA G., BECKER C., TERRIER F. Transarterial chemoembolization in hepatocellular carcinoma.
86. REGALIA E., FASSATI L.R., VALENTE U. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J. Hep. Bil. Pancr Surg., 1998, 5: 29-34.
87. BRUIX J., LLOVET J.M. Prognostic prediction and treatment strategies in hepatocellular carcinoma. Hepatology, 2002, 35: 519-524.
88. SARASIN F. P., MAJNO P. E., LLOVET J. M., BRUIX J., MENTHA G., HADENGUE A. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology; 2001, 33: 1073-9.
89. FIGUERAS J., JAURRIETA E., VALLS C., RAMOS E., SERRANO T., RAFECAS A., FABREGAT J., TORRAS J. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J. Am. Coll. Surg., 2000, 190: 580-7.
90. BIGOURDAN J.M., JAECK D., MEYER N., MEYER C., OUSSOULT-ZOGLOU E., BACHELLIER P., WEBER JC., AUDET M., DOFFOEL M., WOLF P. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl., 2003, 9: 513-20.
91. IWATSUKI S., STARZL T.E., SHEAHAN D.G., YOKOYAMA I., DEMETRIS A.J., TODO S., TZAKIS A.G., VAN THIEL D.H., CARR B., SELBY R. et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann. Surg., 1991, 214: 221-229.
92. MAJNO P.E., SARASIN EP., MENTHA G., HADENGUE A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology, 2000, 31: 899-906.
93. JONAS S., STEINMULLER T., SETTMACHER U., LANGREHR J., MULLER A., NEUHAUS P. Liver transplantation for recurrent hepatocellular carcinoma in Europe. J. Hepatobiliary Pancreat. Surg., 2001, 8: 422-6.
94. LLOVET J.M., BRUIX J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology, 2003, 37: 429-42.
95. KOUROUMALIS E., SKORDILIS P., THERMOS K., VASILAKI A., MOSCHANDREA J., MANOUSOS O.N. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut, 1998, 42: 442-7.
96. YUEN M.F., POON R.T., LAI C.L., FAN S.T., LO C.M., WONG K.W., WONG W.M., WONG B.C. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology, 2002, 36: 687-91. Erratum in: Hepatology, 2003, 37: 489.
97. YUEN M.F., POON R.T., LAI C.L., FAN S.T., LO C.M., WONG K.W., WONG W.M., WONG B.C. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma. Hepatology, 2002, 36: 687-91. Erratum in: Hepatology, 2003, 37: 489.
98. LEUNG T.W., PATT Y.Z., LAU WY., HO S.K., YU S.C., CHAN A.T., MOK T.S., YEO W., LIEW C.T., LEUNG N.W., TANG A.M., JOHNSON P.J. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin. Cancer Res., 1999, 5: 1676-81.
99. FINKELSTEIN S.D., MARSH W., DEMETRIS A.J., SWALSKY P.A., SASATOMI E., BONHAM A., SUBOTIN M., DVORCHIK I. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology, 2003, 37: 871-9.
100. WAGURI N., SUDA T., NOMOTO M., KAWAI H., MITA Y., KUROIWA T., IGARASHI M., KOBAYASHI M., FUKUHARA Y., AOYAGI Y. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma, detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin. Cancer Res., 2003, 9: 3004-11.
101. BARTOLOZZI C., CIONI D., DONETI F., LENCIONI R. Focal liver lesions: MR imaging - pathologic correlation. Eur Radiol. 2001, 11: 1374-88.